In some solid tumors, pharmacological inhibition of CDK4/6 has demonstrated substantial effectiveness, mostly by preventing Rb phosphorylation and causing G1 cell cycle arrest in tumor cells [7]. The gene discussed is CDK4; the disease is neoplasm.